Oppenheimer Reiterates Outperform on Amdocs (DOX) Following Strong 3Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Amdocs (DOX) Tops Q3 EPS by 3c
July 26, 2016 4:02 PM EDTAmdocs (NASDAQ: DOX) reported Q3 EPS of $0.90, $0.03 better than the analyst estimate of $0.87. Revenue for the quarter came in at $930 million versus the consensus estimate of $928.81 million.
Fourth quarter fiscal 2016 guidance: Expected revenue of approximately $920-$960 million. Expected diluted GAAP EPS of approximately $0.66-$0.74.... More
